Tuesday, February 17, 2015

Cancerous Tumor Suctioned and Processed into a Vaccine for Clinical Trials

A patient with metastatic kidney cancer underwent suction of a cancerous tumor. Physicians at Henry Ford Hospital successfully performed a minimally invasive kidney removal after clearing the tumour. The genetic material from his tumor is under trial to produce a vaccine to help fight his metastatic disease. AngioVac employs large suction catheters to filter blood through a cardiac bypass machine and remove clots, tumors or other foreign material. Craig ...

Read More

No comments:

Post a Comment